HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hemant M Kocher Selected Research

Integrins

1/2023Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion.
11/2019The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy.
1/2013RhoC interacts with integrin α5β1 and enhances its trafficking in migrating pancreatic carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hemant M Kocher Research Topics

Disease

32Neoplasms (Cancer)
01/2023 - 01/2005
31Pancreatic Neoplasms (Pancreatic Cancer)
10/2023 - 11/2007
18Adenocarcinoma
01/2023 - 07/2008
7Chronic Pancreatitis
12/2020 - 12/2008
6Neoplasm Metastasis (Metastasis)
10/2023 - 01/2013
3Inflammation (Inflammations)
04/2024 - 06/2014
2Weight Loss (Weight Reduction)
12/2022 - 09/2016
2Carcinogenesis
01/2022 - 06/2014
2Infections
01/2021 - 09/2016
2Pancreatic Diseases (Pancreatic Disease)
08/2020 - 07/2008
2Hepatocellular Carcinoma (Hepatoma)
01/2018 - 01/2014
2Intestinal Neoplasms (Intestinal Cancer)
01/2018 - 12/2013
2Hypertrophy
03/2014 - 09/2012
2Pain (Aches)
12/2011 - 12/2008
1Fibrosis (Cirrhosis)
01/2023
1Jaundice (Icterus)
12/2022
1Compartment Syndromes
05/2022
1Aggressive Fibromatosis (Desmoid)
03/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Tertiary Lymphoid Structures
01/2021
1COVID-19
01/2021
1Obesity
01/2021
1Digestive System Diseases
12/2020
1Urologic Neoplasms (Urological Cancer)
12/2020
1Cholangiocarcinoma
08/2020
1Pathologic Constriction (Stenosis)
04/2019
1Disease Progression
01/2018
1Ovarian Neoplasms (Ovarian Cancer)
01/2018
1Neoplasms, Cystic, Mucinous, and Serous
01/2018
1Necrosis
03/2017
1Vomiting
09/2016

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2023 - 04/2012
7Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2008
6Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2022 - 10/2011
5GemcitabineFDA Link
01/2021 - 11/2007
5Protein Isoforms (Isoforms)IBA
10/2011 - 04/2003
3IntegrinsIBA
01/2023 - 01/2013
3CollagenIBA
01/2020 - 08/2009
3CytokinesIBA
01/2018 - 04/2003
3Cadherins (E-Cadherin)IBA
03/2017 - 08/2009
2DNA (Deoxyribonucleic Acid)IBA
04/2022 - 10/2008
2Conditioned Culture MediaIBA
01/2022 - 01/2019
2LigandsIBA
01/2022 - 01/2017
2AntigensIBA
01/2022 - 01/2021
2Volatile Organic CompoundsIBA
01/2021 - 01/2018
2Indicators and Reagents (Reagents)IBA
01/2020 - 10/2011
2Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA
03/2017 - 05/2013
2ProteomeIBA
08/2015 - 07/2008
2ezrinIBA
12/2013 - 08/2009
2CateninsIBA
05/2013 - 10/2011
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2010 - 11/2007
2Fibrin Tissue Adhesive (Fibrin Sealant)IBA
05/2010 - 11/2007
2Fluorouracil (Carac)FDA LinkGeneric
05/2010 - 11/2007
1Myosin Type IIIBA
10/2023
1SodiumIBA
12/2022
1BilirubinIBA
12/2022
1Alkaline PhosphataseIBA
12/2022
1CreatinineIBA
12/2022
1Metaraminol (Aramine)FDA Link
05/2022
1Histone Deacetylase InhibitorsIBA
01/2022
1Histocompatibility Antigens Class IIIBA
01/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022
1PTX3 proteinIBA
06/2021
1Hyaluronic Acid (Hyaluronan)IBA
06/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2021
1ORALIT (ORS)IBA
01/2021
1Vitamin DFDA LinkGeneric
01/2021
1ChemokinesIBA
01/2021
1Macrophage Colony-Stimulating FactorIBA
01/2020
1perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA
04/2019
1N 563IBA
04/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2019
1Antigen-Antibody Complex (Immune Complex)IBA
01/2019
1Monoclonal AntibodiesIBA
01/2018
1Somatostatin Receptors (Somatostatin Receptor)IBA
01/2018
1Sorafenib (BAY 43-9006)FDA Link
01/2018
1Imatinib Mesylate (Gleevec)FDA Link
01/2018
1Cytotoxins (Cytolysins)IBA
01/2018
1Interleukin-4 (Interleukin 4)IBA
03/2017
1Transforming Growth Factor beta (TGF-beta)IBA
01/2017
1p21-Activated KinasesIBA
01/2017
1C-Reactive ProteinIBA
12/2016
1AlbuminsIBA
12/2016
1Anti-Bacterial Agents (Antibiotics)IBA
09/2016

Therapy/Procedure

12Therapeutics
01/2023 - 07/2014
7Drug Therapy (Chemotherapy)
01/2021 - 11/2007
4Immunotherapy
01/2022 - 01/2021
3Adjuvant Chemotherapy
04/2024 - 11/2007
2Hepatectomy
03/2014 - 09/2012
2Nerve Block (Nerve Blocks)
12/2011 - 12/2008
2Lymph Node Excision (Lymph Node Dissection)
05/2010 - 11/2007
2Pancreaticoduodenectomy
05/2010 - 11/2007
2Combination Drug Therapy (Combination Chemotherapy)
05/2010 - 11/2007
2Pancreaticojejunostomy
05/2010 - 11/2007
2Chemoradiotherapy
05/2010 - 11/2007
1Lab-On-A-Chip Devices
10/2023
1Gastric Bypass (Roux-en-Y Gastric Bypass)
03/2022
1Colectomy
03/2022
1Radiofrequency Ablation
01/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
06/2021